Novartis Pharmaceuticals Global Marketing Manager Salaries in Boston
The average Novartis Pharmaceuticals Global Marketing Manager in Boston earns an estimated $153,249 annually, which includes an estimated base salary of $131,484 with a $21,765 bonus. Novartis Pharmaceuticals' Global Marketing Manager compensation is $27,080 more than the US average for a Global Marketing Manager. Global Marketing Manager salaries at Novartis Pharmaceuticals in Boston can range from $73,000 - $280,000.
In Boston, The Marketing Department at Novartis Pharmaceuticals earns $22,149 more on average than the Operations Department.
Last updated 2 years ago.
- $131,484
- avg. base
- $21,765
- avg. bonus
Global Marketing Manager Salaries at Novartis Pharmaceuticals
In Boston, Global Marketing Managers earn $2,288 more than Global Marketing Managers, and $36,702 less than Directors of Marketing.
Compensation at Novartis Pharmaceuticals by Department
In Boston, The Marketing Department averages $22,149 more than the Operations Department, and $8,924 less than the Design Department
Global Marketing Manager Compensation by Gender (All Companies)
The average female Global Marketing Manager at companies similar size to Novartis Pharmaceuticals reported making $151,576, while the average male Global Marketing Manager at similar sized companies reported making $152,234.
Global Marketing Manager Compensation by Ethnicity (All Companies)
The average African American/Black Global Marketing Manager at companies similar size to Novartis Pharmaceuticals reported making $182,500, while the average Native American Global Marketing Manager at similar sized companies reported making $119,055.
How Global Marketing Managers at Novartis Pharmaceuticals Rate Their Compensation
The majority of Global Marketing Managers at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Global Marketing Managers at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
